Trials / Completed
CompletedNCT02748993
A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Pediatric Atopic Dermatitis
A Randomized, Double-blind, Placebo-Controlled, Parallel Study to Investigate the Safety, Tolerability, Systemic Exposure and Efficacy of PAC-14028 in Children With Mild to Moderate Pediatric Atopic Dermatitis
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 56 (actual)
- Sponsor
- Amorepacific Corporation · Industry
- Sex
- All
- Age
- 24 Months – 12 Years
- Healthy volunteers
- Not accepted
Summary
This is a phase 1 and 2 study to assess the safety and efficacy of PAC-14028 cream in children with atopic dermatitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PAC-14028 Cream 0.1% | Topical application |
| DRUG | PAC-14028 Cream 0.3% | Topical application |
| DRUG | PAC-14028 Cream 1.0% | Topical application |
| DRUG | PAC-14028 Cream Vehicle | Topical application |
Timeline
- Start date
- 2016-03-01
- Primary completion
- 2018-09-01
- Completion
- 2018-10-01
- First posted
- 2016-04-22
- Last updated
- 2018-11-20
Locations
3 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02748993. Inclusion in this directory is not an endorsement.